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Abstract
For my senior project, I perform data analysis using statistical methods to determine body metrics that
correlate with blood glucose levels. Working with Dr. Tina Smilkstein, I take repeat measurements from 6
different volunteers to establish trends in bodily metric data. The data taken includes weight, body fat,
pulse rate, VO2, blood glucose, blood pressure, hours slept, and quality of sleep. Using these values, I use
the program MiniTab to view results.
A few examples of correlations with blood glucose found in this project are:
• Systolic blood pressure for females had a regression line of 124.0 -0.3366*Blood Pressure. This
indicates a negative correlation, meaning as blood pressure rose, blood glucose dropped. For
males, the line equation is 59.47 + 0.2962*Blood Pressure, indicating a positive correlation.
• In the case of diastolic blood pressure, male data was quite scattered graphically, indicating the
line of best fit is not an accurate representation of blood glucose. For females, the line is 111.9 –
0.3565*Blood Pressure (diastolic). This again indicates a negative correlation.
• In the case of weight, both lines graphically followed the data points. For males, the regression
line is 162.6 – 0.342*Weight. For females, it is 103.2- 0.1525*Weight.
• The rest of the correlations and data is found in the contents of the report.
Leveraging the results of this research, patients can potentially input their information into a webpage that
predicts whether or not they must prick their finger to view actual blood glucose. While this tool may
provide an interesting learning opportunity, the numerical value provided is not meant to be taken as
medical advice. Every individual has different bodily metrics, therefore the value given is for
experimentation, not for a 100% accurate measurement. To be sure of your blood glucose, until the
technology has improved, always use a Blood Glucose Monitor, since I am not a medical professional.
Once perfected, this could lead to saved time, pain, and trouble for the user. For the following data, it
reflects 18-24 year old college students without diabetes to establish a baseline.

Chapter 1. Introduction
Using bodily metrics to understand changes in blood glucose and even predict it, my senior
project, implements research to anticipate a patient’s blood glucose levels without puncturing their skin, a
common customer grievance. This research can be leveraged to determine important trends. These trends
may be used to create, potentially, a non-invasive blood glucose monitor. The monitor would measure the
metrics other than blood glucose, allowing a pain-free blood glucose prediction method. The product’s
customers, diabetics or pre-diabetics, can now predict their insulin needs more easily. This project allows
patients to keep a closer eye on their health, without causing unnecessary pain, discomfort, and cost for
doing so. Some blood glucose testing strips cost as much as $1.50 per strip. With testing every time you
eat, this cost could grow over $5 a day. Although this tool is interesting to use, it is in the early stages of
research and should not be taken as medical advice.
The project’s context is a time of changing and quickly advancing medical devices. The biotech
industry continuously advances, with blood glucose monitors constantly needing attention [7]. These
updates make them smaller, faster, more comfortable, and more user accessible. However, not many of
these methods lack a needle pricking the skin of the user [6]. This project adds that layer of customer
compatibility to the market, making it the prime choice for those not wishing to repeatedly puncture
themselves.
Other researchers have explored similar paths, but by using statistics to explore complex trends
and make sense of obscure values, the data becomes much more useful. The need for a blood glucose
prediction method improving patient life quality makes all work done completely necessary. A product
not requiring breaking the skin of patients could revolutionize the blood-glucose monitoring industry,
allowing millions of patients the option to reduce a daily annoyance and physical pain of pricking
themselves to achieve life-saving data. To provide an example, diagnosed type 2 diabetes in the United
States in 2016 totaled at 21 million people. This doesn’t include those with pre-diabetes or undiagnosed
individuals. Some diabetics check their blood glucose up to seven times a day. Total pricks per day, just
in the United States, is 147 million pricks. This leads to over $150 million spent by Americans every day
in the United States. Imagine half of those pricks could be avoided by checking pulse, blood pressure, or
other metrics. Many moments of pain and discomfort can be avoided, as well as nearly $75 million.
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Chapter 2. Customer Needs, Requirements, and Specifications
Customer Needs Assessment
The target customers of this product, diabetes patients, need a method featuring the following:
•
•
•
•

Simple – the measurements taken and webpage used to calculate should be intuitive
Non-invasive – the device provides an external-only solution
Reliable – the customer can trust the prediction made, but not accept it as medical advice
Private – customers’ data does not remain in system beyond their calculation

Requirements and Specifications
The requirements and specifications of this project arose from discussion and revision of original plans
for the project. Inspiration for many of the specifications came from existing products and what the
companies advertise as their most lucrative features. [1] [4]
Subject Selection
In order to choose subjects, the candidates must meet several criteria in the selection process and
measurement process. For example:
• Subjects must not take blood thinners or other medications that interfere with the safety or results.
• Subject’s ages range from 18-24 years old.
• The testing will not impede any costs upon the subjects.
• Preparation for the data collection includes only cleaning the surface of the skin and ensuring the
subject is seated and relaxed.
• The subjects do not experience excessive pain or discomfort during data collection.
• The data is available to subjects at time of collection, and is anonymous.

Step
1
2
3
4
5
6

TABLE IV
WEARABLE ADHESIVE CIRCUIT DELIVERABLES
Delivery Date
Deliverable Description
4/15/2019
5/23/2019
5/6/2019
11/21/2019
2/18/2019
12/31/2019

Design Review
EE 461 demo
EE 461 report
EE 462 demo
ABET Sr. Project Analysis
EE 462 Report

[1] R. Ford and C. Coulston, Design for Electrical and Computer Engineers, McGraw-Hill, 2007, p. 37
[2] IEEE Std 1233, 1998 Edition, p.

1. The first step, design review, was done in the EE460 course at Cal Poly, SLO. This included the
formatting of this report in early stages, involving section creation. Dr. David Braun oversaw this
process. Once complete, the report is handed to the advisor, Dr. Tina Smilkstein, who provides
project feedback. This concludes the design review.
2. The EE 461 demo does not apply for this project, but it consisted of finishing research, gathering
all materials, and preparing for data collection with subjects. This continued into the summer,
where I took weeks of data on myself to perfect the methods and ensure the data taken on subjects
was done quickly and safely.
3. Similar to the EE460 design review, EE461 also requires an update to the advisor on report status
with any new information.
4. The EE 462 demonstration involved setting up the calculator to predict blood glucose with the
regression analysis with the lowest P-values. This was inputted into the calculator-building
website, then presented to Dr. Smilkstein to use and explore. The information for this calculator
was found through several months of data collection from multiple subjects, then compiled and
analyzed using Excel and Minitab. A more detailed time-flow of the project is found below:
a. First, determining which types of data to take and doing research on current blood
glucose measurement techniques.
b. Second, gathering subjects for data collection.
c. Third, gathering data from the subjects, including at least three measurements from each
person first thing in the morning.
d. Fourth, analyzing the data through MiniTab to see which metrics were the most
significant and which could be disregarded.
e. Last, creating a tool for people to use and easily interpret my findings.
5. The ABET Sr. Project Analysis, a required portion of an Electrical Engineering senior project,
was completed in EE460, but redone for the EE462 final report to represent the actual project
once completed, instead of the theoretical project designed in EE460.

6. The EE462 report, this document, includes the data compiled and analyzed using MiniTab 19.
This software allowed me to create linear regression graphs, create regression equations, and
view coefficients to explain the accuracy of predictions. These visual and numerical analyses are
found within this report. To submit this report, it is uploaded to the digital commons of the Cal
Poly library, and approved by the advisor.

7. Results of Statistical Analysis
The results of this research showed interesting correlations. Notably, the differences between the male
and female trends. At first, I analyzed both sexes together. Out of curiosity, I decided to split up male and
female results, showing very interesting data. As a disclaimer, these results always may be a coincidence
for the individuals I tested. Additionally, more subjects, more measurements, and a longer and more
controlled study would improve the trends analyzed in this project.

Figure 2: Blood glucose compared with diastolic blood pressure data.
It became clear that the data taken on females was more indicative of accurate predictions. The reason for
this remains unclear. In Figure 2, we see that generally, male blood glucose rises with diastolic blood
pressure, as expected. However, female blood glucose consistently fell as blood pressure increased. This
may have something to do with stress, exercise, and hormones. The regression equations used are seen
below. Then, the coefficients show that at a 22.7% P-value indicates that diastolic blood pressure alone is
not enough for an accurate prediction of blood glucose.

Regression Equation

M/F
F

Blood Glucose = 102.7 - 0.239 Blood pressure (dia)

M

Blood Glucose = 116.8 - 0.239 Blood pressure (dia)
Coefficients

Term
Coef SE Coef T-Value P-Value VIF
Constant
102.7
15.0
6.84
0.000
Blood pressure (dia) -0.239
0.190
-1.26
0.227 1.00
M/F
M
14.11
3.80
3.72
0.002 1.00

Figure 3: Systolic blood pressure and blood glucose associations.
In Figure 3, the trends follow a similar pattern as Figure 2. Again, the female blood glucose fell as blood
pressure rose, while the male data remained more scattered. This may be due to statistical outliers, stress,
or simply a more consistent trend in female measurements. The actual regression equations for male and
female results are seen below. While graphically, systollic blood presure looks like a good indicator, the
coefficients reveal that when used alone, it is not sufficient to predict blood glucose.
Regression Equation

M/F
F

Blood Glucose

=

103.0 - 0.159 Blood pressure (sys)

M

Blood Glucose

=

118.9 - 0.159 Blood pressure (sys)
Coefficients

Term
Constant
Blood pressure
(sys)
M/F
M

Coef SE Coef T-Value P-Value VIF
103.0
22.6
4.56
0.000
- 0.189
-0.84
0.412 1.33
0.159
15.88

4.48

3.54

0.003 1.33

Figure 4: Blood glucose trends with weight differing between male and female subjects.
In Figure 4, interestingly enough, trends defy expectations. As weight went up, blood glucose when
down. Since all subjects are moderately active 18-24 year olds, I believe their muscle mass may have
caused this phenomenon. Generally, resistance exercise increases muscle mass as well as lowing blood
glucose levels [18]. The male weight correlation contains a higher variety of inputs than female, since
most female data lies from 150-160 lbs.
The regression fit formula of the male correlation line is Blood Glucose = 162.6 - .3420*Weight. This
formula may be used to predict blood glucose based of weight alone for men in the correct age/activity
range.

Regression Equation

M/F
F
Blood
Glucose

M

Blood
Glucose

= 103.2 0.153 Weight

= 162.6 0.342 Weight

The regression equation above shows how to predict blood glucose between males and
females. It is important to categorize sexes since, as seen above, the equations are quite
different.
Coefficients

Term
Constant
Weight

Coef SE Coef T-Value P-Value
103.2
27.5
3.75
0.003

VIF

-0.153

0.189

-0.81

0.437

9.69

59.3

35.3

1.68

0.121

108.50

-0.190

0.222

-0.85

0.412

156.98

M/F
M
Weight*M/F
M

The coefficients of the regression equation explain the statistical significance of the data.

Figure 5: Blood glucose trends analyzed with respect to body fat percentage.
Figure 5 shows that there was very little correlation between blood glucose and body fat percentage.
Some may be seen for males, but the scattered points may not be indicitave of a strong relationship.
Overall, there was a slight downward trend in male blood glucose as body fat increased. For females,
body fat had no correlation with blood glucose, as over a wide range of body fats, blood glucose stayed
relatively constant.
MiniTab, the software used for the figures in this report, also has the ability to make predictions. Using a
regression equation and weighting the male/female categories, Minitab provides an estimation of blood
glucose level. For the calculator I created, I used a slightly different method by splitting up the male and
female equations.
Below are several inputs and outputs of this estimation.
Case 1: Blood pressure and sex
Case 1 represents only blood pressure (diastolic and systolic) and sex as factors in the prediction. I chose
these metrics since from Figure 3, we found that blood pressure, especially in males, led to a low P-value
(likelyhood the prediction is wrong) when predicting blood glucose.

Regression Equation

Blood Glucose = 107.2 + 0.089 Blood pressure (sys) - 0.433 Blood pressure (dia)
+ 0.000000 M/F_F - 78.7 M/F_M + 0.000000 Blood pressure
(sys)*M/F_F
+ 0.142 Blood pressure (sys)*M/F_M + 0.000000 Blood pressure
(dia)*M/F_F
+ 0.937 Blood pressure (dia)*M/F_M
Settings

Variable
Blood pressure (sys)
Blood pressure (dia)
M/F

Setting
126
70
F

Prediction

Fit
88.1743

SE Fit
8.31166

95% CI
(70.2180,
106.131)

95% PI
(62.9093,
113.439)

X

X denotes an unusual point relative to predictor levels used to fit the model.

Case 2: Pulse, weight, blood pressure, and sex
Case 2 represents pulse, weight, blood pressure, and sex as factors in the prediction. I chose these metrics
for a more complete prediciton than in Case 1, while excluding metrics with extremely high P-values or
that had clearly no correlation, graphically. Several different inputs are used to represent varying types of
subjects.

Regression Equation

Blood
Glucose

= 111.5 + 0.055 Pulse Rate - 0.299 Weight - 0.056 Blood
pressure (sys)
+ 0.177 Blood pressure (dia) + 0.000000 M/F_F
+ 32.53 M/F_M

Input 1:
Settings

Variable
Pulse Rate

Setting
80

Weight

150

Blood pressure (sys)

120

Blood pressure (dia)

70

M/F

F
Prediction

Fit
76.7930

SE Fit
95% CI
95% PI
4.90026 (65.7078, 87.8781) (56.9951, 96.5908)

Input 2:
Settings

Variable
Pulse Rate
Weight
Blood pressure (sys)
Blood pressure (dia)
M/F

Setting
55
200
110
75
M

Prediction

Fit
94.4555

SE Fit
95% CI
95% PI
6.18656 (80.4606, 108.451) (72.8932, 116.018)

Input 3:
Settings

Variable
Pulse Rate
Weight
Blood pressure (sys)
Blood pressure (dia)
M/F

Setting
95
135
105
65
F

Prediction

Fit
82.0487

SE Fit
95% CI
95% PI
7.35639 (65.4074, 98.6900) (58.6819, 105.416) X

X denotes an unusual point relative to predictor levels used to fit the model.

Input 4:
Settings

Variable
Pulse Rate
Weight
Blood pressure (sys)
Blood pressure (dia)
M/F

Setting
85
181
135
85
M
Prediction

Fit
102.166

SE Fit
95% CI
95% PI
3.74881 (93.6855, 110.646) (83.6999, 120.632)

The predictions above show interesting trends in the data when compared. All predictions were
within a realistic boundary of blood glucose levels for this age group. Interesting differences
would be when changing two variables and seeing how the blood glucose prediction changed
and which trend it follows, showing which variable is more indicative of blood glucose level.
An example of this would be Case 2, Input 1 and 3. Both are female predictions. Pulse was
increased, but weight decreased. Blood glucose still increased, even though a decrease in weight
indicated a lower blood glucose from the trends. This indicates that pulse is a stronger predictor
in this case.

Conclusion
This project aims to reduce the number of times a person must prick themselves. To begin the
lengthy process of determining the best and most accurate way to do this, my project uses data
collected on 18-24 year old college students without diabetes, to first understand the baseline of
healthy blood glucose. From this data, further research can be done to determine abnormalities
and eventually leverage the information into a device. The goal of this project was reached, with
finding which metrics were most helpful in determining blood glucose. Body fat, VO2, sleep
quality, and sleep length (short term) were ruled out, while weight, pulse, blood pressure, and
sex were found to be significant.
Along with data found, anyone with an internet connection can now roughly predict their blood
glucose. It is important to note that this is not medical advice and I am not a doctor, simply a
researcher. The calculator is found here: https://www.calconic.com/calculator-widgets/bloodglucose-predictor/5dcf37d8893823001e8a7b7c.
In the future, this calculator could be used in a non-invasive blood glucose measuring device.
By using other metrics, the needle pricking the user’s skin becomes unnecessary. The goal of
this project was to begin the process of eliminating metrics that did not predict blood glucose or
had no significant correlation.
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Appendix A. Senior Project Analysis
TABLE V
APPENDIX D — ANALYSIS OF SENIOR PROJECT DESIGN
Please provide the following information regarding your Senior Project and submit to your advisor
along with your final report. Attach additional sheets, for your response to the questions below.
Project Title: Blood Glucose Predicting Algorithm
Student’s Name: Jessica Patterson Student’s Signature:
Advisor’s Name: Tina Smilkstein Advisor’s Initials: Date:
• 1. Summary of Functional Requirements
This easy-to-use, non-invasive method of predicting blood glucose allows users to understand their
bodily metrics better. It exists as a free calculator website to ensure accessibility.
• 2. Primary Constraints
Measuring accurate propagation delay of the signal may be a significant challenge, as several factors
can influence this time measurement. The accuracy of the printed transistors also may affect the
functionality of the monitor. The difficulty of finding subjects affects the timeline of this project.
Many limiting factors affect this project, such as time, test subject availability, and
accuracy/availability of data.
What made your project difficult? What parameters or specifications limited your options or directed
your approach?
Finding and getting subjects to do repeat measurements was the most difficult part of this project. Resources for analysis
were available to me, but driving around to different subjects houses to make it easier for them was time-consuming.

• 3. Economic
• What economic impacts result? Consider:
Human Capital – Humans may not possess the knowledge of how the calculator works, leading to
disbelief in the effectiveness.
Financial Capital – Patients may not have the money to try this calculator on a computer, forcing
them to continue using the painful finger-prick method.
Natural Capital – The use of internet increases energy consumption.
• Costs and benefits accrue after the calculator has been implemented to a limited number of test
subjects to ensure safety and effectiveness. It may take many design-build-test iterations before the
product proves suitable for the general population if the calculator is leveraged into a device.
Original estimated cost of component parts: $500.00

Actual final cost of component parts (at the end of your project): $12.00 to me, about 500 total
including parts provided by Dr. Smilkstein.
Attach a final bill of materials for all components.
Additional equipment costs include shipping costs, compensation for test subjects, and additional
work hours of the engineer once made into a device.
• How much does the project earn? Who profits?
As of now, the project earns no money. It is a free-to-use calculator to make medical testing more
accessible.
• Timing
When do products emerge? How long do products exist? What maintenance or operation costs
exist?
The calculator emerges immediately. If made in to a device, products emerge 3-7 years after creation
due to the need to complete the FDA device approval process [15]. Product lifetime remains
unknown until test subjects can confirm functionality.

Original estimated development time (as of the start of your project), as Gantt or Pert chart: 26
weeks.
Actual development time (at the end of your project), as Gantt or Pert chart: 27 weeks.
After the project ends, others may implement the ideas laid out in this senior project plan to bring the
product to market.
• 4. If manufactured on a commercial basis:
N/A
• 5. Environmental
• Describe any environmental impacts associated with manufacturing or use, explain where they
occur and quantify.
While usage of the calculator does not pose environmental threats, the manufacturing of the device
may release pollutants, depending on the factory’s conditions. Pollution from shipping vehicles also
poses an environmental concern, from large-scale shipping of materials to small-scale shipping to
customers. This likely does not compare with the current pollution levels from large companies. The
device manufacturing can likely take place in an existing factory and share shipping with other
relevant medical devices, reducing the impact.
• Which natural resources and ecosystem services does the project use directly and indirectly?
If made into a product, this item directly uses water and oxygen in the production process for
machinery and uses plant materials when producing the substrate cloth. The product indirectly uses
habitats for animals through deforestation to achieve plant materials to produce paper for user

manuals.
• Which natural resources and ecosystem services does the project improve or harm?
This project improves the quantity of paper due to the reduced need for blood testing strips and
plastic materials to create the testing devices. It harms the atmosphere through vehicle exhaust
shipping and transportation.
• How does the project impact other species?
This project impacts other species indirectly by taking natural resources such as water and trees,
leading to habitat reduction.
• 6. Manufacturability
Manufacturing difficulties may include finding a location for manufacturing, paying for the
necessary materials and space for large scale production, and surpassing legal barriers for
manufacturing.
• 7. Sustainability
• Describe any issues or challenges associated with maintaining the completed device, or system.
If the device does not last as long as intended, production costs may increase to an unsustainable
amount. In addition, customers may choose not to purchase the device more than once if it does not
last.
• Describe how the project impacts the sustainable use of resources.
The project reduces the use of paper test strips and reduces the need for multiple devices through the
ability to recharge and reuse the device.
• Describe any upgrades that would improve the design of the project.
To upgrade the concept, a manufacturer could add functionality such as heart rate monitoring, drug
level monitoring, and devise a plan for insulin depositing.
• Describe any issues or challenges associated with upgrading the design.
The requirement that the device does not need to prick the user causes an issue with adding insulin
depositing functionality
• 8. Ethical

Describe ethical implications relating to the design, manufacture, use, or misuse of the project.
Analyze using one or more ethical frameworks in addition to the IEEE Code of Ethics.
The first ethical framework of the IEEE Code of Ethics states:
“to hold paramount the safety, health, and welfare of the public, to strive to comply with ethical design and
sustainable development practices, and to disclose promptly factors that might endanger the public or the
environment”

The desire to provide a device related to the health of those with diabetes upholds the ideals of this
code.
The fifth ethical framework states:
“to improve the understanding by individuals and society of the capabilities and societal implications of
conventional and emerging technologies, including intelligent systems”

The desire to reduce pain involved with glucose monitoring ensures that the project understands the
complaints of society and strives to provide an alternative method.
The misuse of this product does not cause problems, since the only functionality provides blood
glucose monitoring, which likely does not involve sinister intentions.
• 9. Health and Safety
Describe any health and safety concerns associated with design, manufacture or use of the project.
The application of current to the human body may concern some users. However, the amount of
current used does not harm the user as long as they do not have any electrical components already
inside them, such as a pacemaker.
• 10. Social and Political
• Describe social and political issues associated with design, manufacture, and use.
The rigorous and lengthy FDA approval process may cause an issue with bringing the product to
market. However, this process ensures the upmost quality of the device.
• Who does the project impact? Who are the direct and indirect stakeholders?
This project effects manufacturers of materials, patients with diabetes, doctors, competitors, and
investors. It directly effects engineers and patients.
• How does the project benefit or harm various stakeholders?
The project benefits those earning a profit or receiving important data from the product, such as
engineers, shipping companies, material manufacturers, and patients. However, competing

companies may endure financial harm if their products lose popularity.
• To what extent do stakeholders benefit equally? Pay equally? Does the project create any
inequities?
Engineers and investors likely earn much more than shipping contractors and materials
manufacturers. However, due to decreased involvement by the latter, this difference in pay does not
cause concern.
• Consider various stakeholders’ locations, communities, access to resources, economic power,
knowledge, skills, and political power.
The access to resources may affect the benefits of the patients, depending on whether or not they live
in a developed country, have access to electricity, earn an income, and more. These people have
unfair limitations placed on them and may not receive the product at any point.
• 11. Development
Describe any new tools or techniques, used for either development or analysis you learned
independently during the project’s course.
Please see page 9’s bibliography.
Through this literature search, I learned about marketing medical devices, common medical device
specifications, and the various blood glucose monitoring methods currently on the market.

Apendix B. Project Planning

EE 460 Gantt Chart for Winter Quarter, 2019 listing recommended work periods (green lines),
due dates (blue triangles), and when the project requires feedback (circle of arrows).

EE 461 Gantt Chart for Spring Quarter, 2019 including work periods and due dates for design,
test, and build cycles.

EE 462 Gantt Chart for Fall Quarter, 2019 including work periods and due dates for the final
design, test, and build cycles. This also includes the senior project expo and conclusion of the
project.

